Canada Gazette, Part I, Volume 157, Number 6: GOVERNMENT NOTICES

February 11, 2023

DEPARTMENT OF HEALTH

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Guidance on Improving Indoor Air Quality in Office Buildings

Pursuant to subsection 55(3) of the Canadian Environmental Protection Act, 1999, the Minister of Health hereby gives notice of the Guidance on Improving Indoor Air Quality in Office Buildings. The document is available from February 11, 2023, to April 10, 2023, on Health Canada’s consultation webpage. Any person may, within 60 days after publication of this notice, file with the Minister of Health written comments on the guide. Comments should be sent by email to air@hc-sc.gc.ca.

February 11, 2023

Greg Carreau
Director General
Safe Environments Directorate
On behalf of the Minister of Health

ANNEX

The quality of the air in an office building is the result of the complex interactions between the ventilation system, the building (i.e. age, condition, component materials, structure, and envelope), the climate, the quality of the outdoor air, the furnishings and products present, the work processes, and the occupants and their activities. Some factors that contribute to poor indoor air quality (IAQ) may be related to building stewardship activities such as maintenance and housekeeping; inadequate ventilation system design or maintenance; or selection and use of equipment, furnishings, building materials, office supplies and cleaning chemicals.

This guide addresses issues relating to IAQ that are common in an office building setting, while promoting good prevention practices. It provides guidance to help manage and resolve IAQ issues promptly and encourages consistency and transparency throughout the IAQ assessment, investigation, and resolution process. Good operational practices can prevent many IAQ issues. However, if IAQ issues do arise, they can be addressed by implementing corrective actions after identifying the potential cause(s). This document also provides guidance for maintaining good IAQ once corrective actions have been taken.

This guide applies to any size office building in Canada. It applies to non-industrial and non-residential workplace settings and includes buildings with meeting rooms, lunchrooms, and small kitchens, and which have a limited number of hazardous products on site.

While this guide provides advice for employers and building operators to help resolve IAQ issues, there may be situations that will require the services of a person qualified in heating, ventilation, and air conditioning (HVAC) or in occupational hygiene.

Preventing IAQ issues before they arise and addressing issues as soon as they are identified is the best strategy for building operators and employers. Good practices to maintain IAQ include the following:

DEPARTMENT OF HEALTH

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Objective for Canadian Drinking Water Quality — Per- and Polyfluorinated Substances in Drinking Water

Pursuant to subsection 55(3) of the Canadian Environmental Protection Act, 1999, the Minister of Health hereby gives notice of a proposed Objective for Canadian Drinking Water Qualit— Per- and Polyfluorinated Substances. The proposed objective technical document will be available from February 11, 2023, to April 12, 2023, on the Health Canada consultation webpage. Any person may, within 60 days after publication of this notice, file with the Minister of Health written comments on the proposed document. Comments must be sent by email at water-eau@hc-sc.gc.ca.

February 11, 2023

Greg Carreau
Director General
Safe Environments Directorate
On behalf of the Minister of Health

ANNEX

Proposed objective

To reduce exposure from drinking water, an objective of 30 ng/L is proposed for the sum of total per- and polyfluoroalkyl substances (PFAS) detected in drinking water. Total PFAS should be calculated using the full list of substances in either United States Environmental Protection Agency (U.S. EPA) Method 533 or U.S. EPA Method 537.1, or both, or another approved method (see full proposal). A jurisdiction could also validate and apply an alternate analytical method that quantifies a minimum of 18 PFAS. For the purposes of this proposed objective, a result of non-detect is considered to have a value of zero. It is recommended that treatment plants strive to maintain PFAS concentrations in drinking water as low as reasonably achievable.

Background

This proposed objective was prepared in collaboration with the Federal-Provincial-Territorial Committee on Drinking Water and is based on potential health concerns for the group of PFAS, as well as treatment and analytical considerations.

In 2018 and 2019, Health Canada established drinking water guidelines for perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA), and screening values for nine other PFAS. These values applied to water intended for human consumption.

On April 24, 2021, the Government of Canada notified people living in Canada of its intent to move forward with activities that address PFAS as a class. In accordance with this strategy and considering new scientific evidence in the field of hazard and exposure assessment as well as in treatment and analytical technologies, a review of the existing PFAS drinking water guidelines and screening values is underway. Given the potential for exposure to multiple PFAS at the same time, the potential for negative health impacts, the uncertainty and the limited data on many PFAS, a precautionary group-based approach to PFAS is warranted.

To reduce potential exposure to PFAS through drinking water while the reassessment of the guidelines and screening values is being completed, an objective based on the sum of specific detected PFAS is proposed for Canadian drinking water. This proposed objective, when finalized, will replace the two existing drinking water guidelines and nine screening values derived for individual PFAS. This technical document was prepared in collaboration with the Federal-Provincial-Territorial Committee on Drinking Water.

Health considerations

Toxicological and epidemiological information is available for only a limited number of PFAS. Based on the available information, it is evident that exposure to certain PFAS has the potential to affect multiple systems and organs. Many of the effects seen in humans are supported by experimental studies in animal models. New information on well-studied PFAS shows effects at lower levels than previous studies. Canadians are exposed to multiple PFAS simultaneously as can be seen from biomonitoring data.

A traditional health-based approach was not adopted to derive the proposed objective in part due to the rapidly evolving science. The science is complex, there is currently no consensus regarding the most sensitive health effects, and approaches to hazard and risk assessment are varied.

Analytical and treatment considerations

The establishment of the proposed drinking water objective considers the ability to both measure the contaminant and remove it from drinking water supplies. Several analytical methods are available for measuring some PFAS in water at concentrations below the proposed objective.

At the municipal level, established treatment technologies that are available to effectively decrease PFAS concentrations in drinking water include granular activated carbon, anion exchange and reverse osmosis. These technologies are capable of achieving treated water concentrations below the proposed objective for individual PFAS. However, to achieve these concentrations, the treatment systems need to be configured and operated properly. Achieving such low concentrations may also lead to challenging operating conditions. Disposal of contaminated filtration media and concentrated residual water will also present challenges.

Residential-scale (i.e. private well) water treatment technologies

In cases where PFAS removal is desired at a small system or household level, for example, when the drinking water supply is from a private well, a residential drinking water treatment unit may be an option. Treatment devices can be certified to NSF Standard 53 (GAC) and NSF Standard 58 (RO) [NSF International, 2021a, b] for the reduction of “total PFAS” in drinking water for the following seven PFAS: PFHpA, PFOA, PFNA, PFDA, PFBS, PFHxS and PFOS. These revised criteria will be published in NSF Standard 53 and NSF Standard 58 in early 2023. The use of treatment devices certified to the revised criteria will help homeowners further reduce their exposure to PFAS from drinking water.

DEPARTMENT OF INDUSTRY

Order appointing directors to the Board of Directors of the College of Patent Agents and Trademark Agents

The Minister of Industry, pursuant to subsection 13(3) of the College of Patent Agents and Trademark Agents Act footnote a, hereby appoints Iris Almeida-Côté and Amber Batool to be directors of the Board of Directors of the College of Patent Agents and Trademark Agents, to hold office during good behaviour for a term beginning immediately and ending on the day that is three years after the day on which the 2022 annual general meeting was held, or at the conclusion of the 2025 annual general meeting, whichever occurs first.

Ottawa, January 23, 2023

François-Philippe Champagne
Minister of Industry

DEPARTMENT OF INDUSTRY

INVESTMENT CANADA ACT

Amounts for the year 2023

Limits for World Trade Organization investors

Pursuant to subsections 14.1(1) and (2) of the Investment Canada Act, I hereby determine that the amount for the year 2023, equal to or above which an investment is reviewable, is 1.287 billion dollars.

Limits for World Trade Organization investors that are state-owned enterprises

Pursuant to subsections 14.1(1.1) and (2) of the Investment Canada Act, I hereby determine that the amount for the year 2023, equal to or above which an investment is reviewable, is 512 million dollars.

Limits for trade agreement investors

Pursuant to subsections 14.11(1), (2) and (3) of the Investment Canada Act, I hereby determine that the amount for the year 2023, equal to or above which an investment is reviewable, is 1.931 billion dollars.

François-Philippe Champagne
Minister of Industry

DEPARTMENT OF TRANSPORT

AERONAUTICS ACT

Interim Order Respecting Certain Requirements for Civil Aviation Due to COVID-19, No. 76

Whereas the annexed Interim Order Respecting Certain Requirements for Civil Aviation Due to COVID-19, No. 76 is required to deal with a significant risk, direct or indirect, to aviation safety or the safety of the public;

Whereas the provisions of the annexed Order may be contained in a regulation made under sections 4.71footnote b and 4.9footnote c, paragraphs 7.6(1)(a)footnote d and (b)footnote e and section 7.7footnote f of the Aeronautics Act footnote g;

And whereas, in accordance with subsection 6.41(1.2)footnote h of that Act, the Minister of Transport has consulted with the persons and organizations that the Minister considers appropriate in the circumstances before making the annexed Order;

Therefore, the Minister of Transport makes the annexed Interim Order Respecting Certain Requirements for Civil Aviation Due to COVID-19, No. 76 under subsection 6.41(1)footnote g of the Aeronautics Act footnote f.

Ottawa, January 30, 2023

Omar Alghabra
Minister of Transport

Interim Order Respecting Certain Requirements for Civil Aviation Due to COVID-19, No. 76

Interpretation

Definitions

1 (1) The following definitions apply in this Interim Order.

air carrier
means any person who operates a commercial air service under Subpart 1, 3, 4 or 5 of Part VII of the Regulations. (transporteur aérien)
COVID-19
means the COVID-19 coronavirus disease. (COVID-19)
COVID-19 antigen test
means a COVID-19 screening or diagnostic immunoassay that
  • (a) detects the presence of a viral antigen indicating the presence of COVID-19;
  • (b) is authorized for sale or distribution in Canada or in the jurisdiction in which it was obtained;
  • (c) if the test is self-administered, is observed and produces a result that is verified
    • (i) in person by an accredited laboratory or testing provider, or
    • (ii) in real time by remote audiovisual means by the accredited laboratory or testing provider that provided the test; and
  • (d) if the test is not self-administered, is performed by an accredited laboratory or testing provider. (test antigénique de la COVID-19)
COVID-19 molecular test
means a COVID-19 screening or diagnostic test, including a test performed using the method of polymerase chain reaction (PCR) or reverse transcription loop-mediated isothermal amplification (RT-LAMP), that
  • (a) if the test is self-administered, is observed and produces a result that is verified
    • (i) in person by an accredited laboratory or testing provider, or
    • (ii) in real time by remote audiovisual means by the accredited laboratory or testing provider that provided the test; or
  • (b) if the test is not self-administered, is performed by an accredited laboratory or testing provider. (test moléculaire de la COVID-19)
COVID-19 test
means either
  • (a) a COVID-19 molecular test, or
  • (b) a COVID-19 antigen test. (test relatif à la COVID-19)
Regulations
means the Canadian Aviation Regulations. (Règlement)
testing provider
means
  • (a) a person who may provide COVID-19 screening or diagnostic testing services under the laws of the jurisdiction where the service is provided; or
  • (b) an organization, such as a telehealth service provider or pharmacy, that may provide COVID-19 screening or diagnostic testing services under the laws of the jurisdiction where the service is provided and that employs or contracts with a person referred to in paragraph (a). (fournisseur de services de tests)

Interpretation

(2) Unless the context requires otherwise, all other words and expressions used in this Interim Order have the same meaning as in the Regulations.

Conflict

(3) In the event of a conflict between this Interim Order and the Regulations or the Canadian Aviation Security Regulations, 2012, the Interim Order prevails.

COVID-19 Tests

Application

2 This Interim Order applies to a private operator or air carrier operating a flight referred to in subsection 2(1) of the Minimizing the Risk of Exposure to COVID-19 in Canada Order.

Prohibition

3 (1) A private operator or air carrier must not permit a person to board an aircraft for a flight that they operate if the person does not provide evidence that they received

Exception

(2) However, a person listed in any of paragraphs 2(2)(a) to (g) of the Minimizing the Risk of Exposure to COVID-19 in Canada Order is not required to provide the evidence referred to in subsection (1).

Evidence of COVID-19 test

4 Evidence of a result for a COVID-19 test must include

Designated Provision

Designation

5 (1) The provision of this Interim Order set out in column 1 of the schedule is designated as a provision the contravention of which may be dealt with under and in accordance with the procedure set out in sections 7.7 to 8.2 of the Act.

Maximum amounts

(2) The amounts set out in column 2 of the schedule are the maximum amounts of the penalty payable in respect of a contravention of the designated provision set out in column 1.

Notice

(3) A notice referred to in subsection 7.7(1) of the Act must be in writing and must specify

Repeal

6 The Interim Order Respecting Certain Requirements for Civil Aviation Due to COVID-19, No. 75, made on January 17, 2023, is repealed.

SCHEDULE

(Subsections 5(1) and (2))

Designated Provision

Column 1

Designated Provision

Column 2

Maximum Amount of Penalty ($)

Individual Corporation
Subsection 3(1) 5,000 25,000

INNOVATION, SCIENCE AND ECONOMIC DEVELOPMENT CANADA

RADIOCOMMUNICATION ACT

Notice No. SMSE-003-23 — Release of RSS-132, issue 4, SRSP-503, issue 8, and Addendum to SRSP-502, issue 5

Notice is hereby given that Innovation, Science and Economic Development Canada has published the following documents:

These documents are now official and available on the Published documents page of the Spectrum management and telecommunications website.

Submitting comments

Comments and suggestions for improving these documents may be submitted online using the Standard Change Request form.

January 31, 2023

Martin Proulx
Director General
Engineering, Planning and Standards Branch

PRIVY COUNCIL OFFICE

Appointment opportunities

We know that our country is stronger — and our government more effective — when decision-makers reflect Canada’s diversity. The Government of Canada has implemented an appointment process that is transparent and merit-based, strives for gender parity, and ensures that Indigenous peoples and minority groups are properly represented in positions of leadership. We continue to search for Canadians who reflect the values that we all embrace: inclusion, honesty, fiscal prudence, and generosity of spirit. Together, we will build a government as diverse as Canada.

We are equally committed to providing a healthy workplace that supports one’s dignity, self-esteem and the ability to work to one’s full potential. With this in mind, all appointees will be expected to take steps to promote and maintain a healthy, respectful and harassment-free work environment.

The Government of Canada is currently seeking applications from diverse and talented Canadians from across the country who are interested in the following positions.

Current opportunities

The following opportunities for appointments to Governor in Council positions are currently open for applications. Every opportunity is open for a minimum of two weeks from the date of posting on the Governor in Council appointments website.

Governor in Council appointment opportunities
Position Organization Closing date
Director Asia-Pacific Foundation of Canada  
Director Atomic Energy of Canada Limited  
Director Bank of Canada  
Chairperson Business Development Bank of Canada  
Director Business Development Bank of Canada  
Director Canada Council for the Arts  
Director Canada Deposit Insurance Corporation  
Director Canada Foundation for Sustainable Development Technology  
President Canada Lands Company Limited  
Director Canada Post Corporation  
Director Canada Revenue Agency  
Chairperson Canadian Air Transport Security Authority  
Chief Executive Officer Canadian Air Transport Security Authority  
Director Canadian Broadcasting Corporation  
Director Canadian Commercial Corporation  
Member Canadian Cultural Property Export Review Board  
Director Canadian Energy Regulator  
Chairperson Canadian High Arctic Research Station  
Member Canadian High Arctic Research Station  
Vice-Chairperson Canadian High Arctic Research Station  
Chief Commissioner Canadian Human Rights Commission  
Pay Equity Commissioner Canadian Human Rights Commission  
Member Canadian Human Rights Tribunal  
Member Canadian Institutes of Health Research  
President Canadian Institutes of Health Research  
Secretary Canadian Intergovernmental Conference Secretariat  
Trustee Canadian Museum of Immigration at Pier 21  
Chairperson Canadian Museum of Nature  
Permanent Member Canadian Nuclear Safety Commission  
President Canadian Nuclear Safety Commission  
Member Canadian Statistics Advisory Council  
Chairperson Canadian Transportation Accident Investigation and Safety Board  
Member Canadian Transportation Accident Investigation and Safety Board  
Member Canadian Transportation Agency  
Chairperson Export Development Canada  
Director Export Development Canada  
Director First Nations Financial Management Board  
Deputy Administrator Fund for Railway Accidents Involving Designated Goods  
Member Historic Sites and Monuments Board of Canada  
Commissioner International Commission on the Conservation of Atlantic Tunas  
President International Development Research Centre  
Commissioner International Joint Commission  
Director Invest in Canada Hub  
Commissioner Law Commission of Canada  
President Law Commission of Canada  
Chairperson Military Grievances External Review Committee  
Vice-Chairperson Military Grievances External Review Committee  
Chairperson National Arts Centre Corporation  
Chairperson National Capital Commission  
Member National Capital Commission  
Member National Farm Products Council  
Vice-Chairperson National Farm Products Council  
Director National Gallery of Canada  
Member Net-Zero Advisory Body  
Canadian Representative North Atlantic Salmon Conservation Organization  
Canadian Representative North Pacific Anadromous Fish Commission  
Public Sector Integrity Commissioner Office of the Public Sector Integrity Commissioner  
Member Pacific Pilotage Authority  
Chairperson Patented Medicine Prices Review Board  
Commissioner Public Service Commission  
Chairperson Royal Canadian Mounted Police Management Advisory Board  
Member Royal Canadian Mounted Police Management Advisory Board  
Vice-Chairperson Royal Canadian Mounted Police Management Advisory Board  
Principal Royal Military College of Canada  
Deputy Administrator Ship-source Oil Pollution Fund  
Executive Director Telefilm Canada  
Chief Executive Officer VIA Rail Canada Inc.  
Chief Executive Officer Windsor-Detroit Bridge Authority